Our Solutions

Press Releases


  • Press Release

    Algorithme Pharma Signs Strategic Alliance with University of Montreal Hospital Research Centre (CRCHUM)

    Oct 29, 2013

    Algorithme Pharma is pleased to announce the signing of a strategic alliance with the University of Montreal Hospital Research Centre (CRCHUM), allowing for access to an extensive pool of patients and the new 520,000 sq. ft. research complex (CRCHUM) for conducting complex early stage clinical trials

  • Press Release

    Vince and Associates Clinical Research Joins the Altasciences Group

    May 13, 2013

    (Laval, Québec, Canada May 14, 2013) – The Altasciences Group is proud to announce the addition of Vince and Associates Clinical Research to its team providing comprehensive Phase I/IIa clinical drug development capabilities.

  • Press Release

    SQI Diagnostics and Algorithme Pharma Provide Update on Multiplex Heparin Immunogenicity Assay

    Mar 24, 2013

    Collaborative results recently presented at the 14th Annual Immunogenicity for Biotherapeutics Conference in Baltimore 18-20 March TORONTO - SQI Diagnostics Inc. (TSX-V: SQD), a life sciences and diagnostics company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics (“SQI”), and Algorithme Pharma (“Algorithme”) today announced that they have completed the multiplexed proof of concept assay targeted at immunogenicity testing of heparin and heparin-based low molecular weight (LMWT) biosimilar compounds using SQI’s Ig_PLEX™ multiplexing technology.

  • Press Release

    Lab Bio-Medic, Algorithme Pharma Sign Partnership

    Feb 13, 2013

    Montreal, February 14, 2013 – Lab Bio-Medic and Algorithme Pharma are pleased to announce that they have signed a partnership agreement for the delivery of biomedical analysis required as part of clinical research projects conducted on behalf of pharmaceutical and biotech customers of this world leader in the conduct of Phase I / IIa and bioequivalence clinical trials.  

  • Press Release

    Algorithme Pharma and SQI Diagnostics to Develop Multiplex Heparin Immunogenicity Assay

    Jan 27, 2013

    Laval, Quebec, January 25, 2013 – Algorithme Pharma and SQI Diagnostics’ (“SQI”) announced that they are using SQI’s Ig_PlexTM multiplexing technology to develop a multiplex proof of concept assay targeted at immunogenicity testing of heparin and heparin-based low molecular weight (LMWT) compounds.

  • Press Release

    Critical Outcome Technologies Inc. announced today it has engaged Algorithme Pharma Inc.

    Feb 7, 2012

    London, Ontario: Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT)announced today that it has engaged Algorithme Pharma Inc. (Algorithme) of Montreal, Canada, aninternationally recognized contract research organization, to develop and validate the final quantitativemethod to be used for preclinical and Phase 1 studies for COTI‐2. 

  • Press Release

    Sensitivity and Speed: Bioanalysis Development at Algorithme Pharma

    Feb 7, 2012

    We are proud to offer next generation technology to address increasing challenges of metabolite identification and protein and peptide quantitation.  In working to best address the needs of our clients, we are now conducting analysis using AB Sciex QTrap 5500 and the highly selective MRM3.

This site uses cookies to store information on your computer and improve your browsing experience. By remaining on this site, you consent to the placement of these cookies. Read our Cookie Policy to learn more.